Literature DB >> 786891

Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

R D Diamond, A C Allison.   

Abstract

Studies were performed to identify the types of human peripheral blood leukocytes capable of killing Cryptococcus neoformans in the presence of anticryptococcal antibody in vitro. A total of 24.1 +/- 2.7% (mean +/- standard error of the mean of four experiments) of the original cryptococcal inoculum survived in a mixed mononuclear, cell preparation (approximately 30% monocytes) after 4 h of incubation at 37 degrees C with rabbit anticryptococcal antibody. When phagocytic cells were removed, there was 36.4 +/- 4.6% survival in six experiments, compared with 52.8% survival in the presence of purified granulocytes (mean of two experiments) and 96.9 +/- 1% survival in the presence of purified T cells. There was never any significant killing in control mixtures that contained leukocytes with normal rabbit serum nor in those that contained anticryptococcal antibody without effector leukocytes. Significant antibody-dependent fungicidal activity was seen with ratios of effector to target cells as low as 6.25:1. These observations indicate that multiple types of peripheral blood leukocytes, excluding T cells, are capable of antibody-dependent fungicidal activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786891      PMCID: PMC420945          DOI: 10.1128/iai.14.3.716-720.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum.

Authors:  G Holm; S Hammarström
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells.

Authors:  R D Diamond
Journal:  Nature       Date:  1974-01-18       Impact factor: 49.962

4.  Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes.

Authors:  I C MacLennan; A Howard; F M Gotch; P G Quie
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

5.  Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses.

Authors:  A Larsson; P Perlmann; J B Natvig
Journal:  Immunology       Date:  1973-10       Impact factor: 7.397

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

8.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance.

Authors:  P Davies; R C Page; A C Allison
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  42 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

Authors:  R D Diamond
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

4.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans.

Authors:  R A Fromtling; R Blackstock; N K Hall; G S Bulmer
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

Review 10.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.